refractory disease (n Z 49) (P Z 0.26). 3-year PFS was 80%, 67%, and 54%, respectively (P Z 0.12). In patients with progressive disease limited to 1 side of the diaphragm, 3-year OS was 100% (relapsed, with RT), 91% (relapsed, no RT), and 72% (refractory) (P Z 0.01), and PFS was 80%, 74%, and 56% (P Z 0.09), respectively. One case of grade >2 RT-related toxicity was observed. This patient had grade 3 cytopenia. Conclusion: This series, the largest of its kind, suggests that patients experience improved outcomes and limited toxicity when RT is provided after SCT for relapsed/refractory HL. Small sample size and selection bias limit the results. Prospective study is warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.